Faculty Practice Associates 17 E 102Nd St, New York, NY 10029 2122416585 (Phone)
Mt Sinai Primary Care 17 E 102Nd St Suite D, New York, NY 10029 2122416585 (Phone)
Certifications:
Internal Medicine, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School Perelman School of Medicine University of Pennsylvania Graduated: 1996 Medical School Hospital Of The University Of Pennsylvania Graduated: 1996
Dr. David T Stern, New York NY - MD (Doctor of Medicine)
Faculty Practice Associates 17 E 102Nd St, New York, NY 10029 2122416585 (Phone)
Mt Sinai Primary Care 17 E 102Nd St Suite D, New York, NY 10029 2122416585 (Phone)
Certifications:
Internal Medicine, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School Vanderbilt University School Of Medicine Graduated: 1989 Medical School Tufts New England Mc Graduated: 1990 Medical School Tufts New England Mc Graduated: 1992 Medical School Palo Alto Va/Stanford Graduated: 1992
Dr. David A Stern, Bronx NY - MD (Doctor of Medicine)
Palm Beach Medical Group 4601 N Congress Ave, West Palm Beach, FL 33407 5618404600 (phone), 5618404680 (fax)
Palm Beach Medical Group 500 University Blvd STE 106, Jupiter, FL 33458 5617479600 (phone), 5618404680 (fax)
Education:
Medical School Philadelphia College of Osteopathic Medicine Graduated: 1979
Procedures:
Allergen Immunotherapy Destruction of Benign/Premalignant Skin Lesions Electrocardiogram (EKG or ECG) Pulmonary Function Tests Vaccine Administration
Conditions:
Abdominal Hernia Acne Anxiety Dissociative and Somatoform Disorders Atherosclerosis Atrial Fibrillation and Atrial Flutter
Languages:
English Spanish
Description:
Dr. Stern graduated from the Philadelphia College of Osteopathic Medicine in 1979. He works in West Palm Beach, FL and 1 other location and specializes in Internal Medicine. Dr. Stern is affiliated with John F Kennedy Medical Center North Campus and Jupiter Medical Center.
Medical School Kansas City University of Medicine and Biosciences College of Osteopathic Medicine Graduated: 2002
Procedures:
Electrocardiogram (EKG or ECG)
Conditions:
Intervertebral Disc Degeneration Spinal Stenosis
Languages:
English
Description:
Dr. Stern graduated from the Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 2002. He works in Omaha, NE and specializes in Anesthesiology. Dr. Stern is affiliated with CHI Health Bergan Mercy.
David Stern - Great Neck NY Shi Du Yan - New York NY Ann Marie Schmidt - Franklin Lakes NJ Ira Lamster - Wyckoff NJ
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K 3800
US Classification:
530324, 530300
Abstract:
The present method provides for an isolated peptide having an amino acid sequence corresponding to the amino acid sequence of a V-domain of a receptor for advanced glycation endproduct (RAGE). The present invention also provides for an isolated peptide having an amino acid sequence A-Q-N-I-T-A-R-I-G-E-P-L-V-L-K-C-K-G-A-P-K-K-P-P-Q-R-L-E-W-K (SEQ. ID No: 1). The present invention provides for a pharmaceutical composition comprising a therapeutically effect amount of an isolated peptide having an amino acid sequence corresponding to the amino acid sequence of a V-domain of RAGE. The present invention also provides for a method for inhibiting interaction of an amyloid- peptide with a receptor for advanced glycation end product which is on the surface of a cell, which comprises contacting the cell with the peptide or a functionally equivalent agent, wherein the peptide or agent is capable of inhibiting interaction of the amyloid- peptide with the receptor for advanced glycation end product, and the peptide or agent is present in an amount effective to inhibit interaction of the amyloid- peptide with the receptor for advanced glycation endproduct.
Transgenic Mice Over-Expressing Receptor For Advanced Glycation Endproduct (Rage) And Mutant App In Brain And Uses Thereof
David M. Stern - Great Neck NY Ann Marie Schmidt - Franklin Lakes NJ Shi Du Yan - New York NY
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
G01N 3300
US Classification:
800 3, 800 12, 800 18
Abstract:
The invention provides for a non-human transgenic animal whose cells contain a recombinant DNA sequence comprising: (a) a nerve tissue specific promoter operatively linked to a DNA sequence which encodes human receptor for advanced glycation endproducts (RAGE), and (b) a nerve tissue specific promoter operatively linked to a DNA sequence encoding a mutant human amyloid precursor protein hAPP695, hAPP751 and hAPP770 bearing mutations linked to familial Alzheimers disease in humans, wherein said non-human transgenic animal exhibits at least one phenotype from the group consisting of: increased expression of M-CSF gene in cerebral cortex; increased expression of IL-6 gene in cerebral cortex; increased neuronal stress; increased neurotoxicity; neuron loss; increased level of activated form of caspase 3 in brain; and increased level of phosphorylated tau protein in brain.
Method To Increase Cerebral Blood Flow In Amyloid Angiopathy
The present invention provides a method for decreasing cerebral vasoconstriction in a subject suffering from chronic or acute cerebral amyloid angiopathy which comprises administering to the subject an inhibitor of receptor for advanced glycation endproduct (RAGE) in an effective amount to inhibit transcytosis of amyloid peptides across the blood-brain barrier in the subject, thereby decreasing cerebral vasoconstriction in the subject. The invention further provides for a method for ameliorating neurovascular stress in a subject which comprises administering to the subject an effective amount of an inhibitor of receptor for advanced glycation endproduct (RAGE), so as to increase cerebral blood flow in the subject, thereby ameliorating neurovascular stress in the subject.
Endothelial Monocyte Activating Polypeptide Ii: A Mediator Which Activates Host Response
David M. Stern - Great Neck NY Matthias Clauss - Bad Nauheim, DE Janet Kao - New York NY Mark Kayton - New York NY Steven K. Libutti - Fort Lee NJ
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K 3800
US Classification:
514 12, 514 13
Abstract:
The present invention provides for a purified endothelial monocyte activating polypeptide II, wherein the polypeptide has an apparent molecular weight of about 20,000 Daltons. The present invention also provides for an effector cell activating protein comprising a polypeptide having an amino acid sequence wherein at least four amino acid residues are the same as RIGRTVT and are in the same relative positions. The invention also provides for a DNA which encodes the effector cell activating protein. The invention also provides for methods of inducing inflammation in a subject and methods of treating tumors in a subject. The invention also provides for a pharmaceutical composition which comprises the endothelial monocyte activating polypeptide II and a carrier.
The present invention provides a method for treating symptoms of diabetes in a diabetic subject which comprises administering to the subject a therapeutically effective amount of an agent which inhibits binding of advanced glycation endproducts to any receptor for advanced glycation endproducts so as to treat chronic symptoms of diabetes in the subject.
Method To Increase Cerebral Blood Flow In Amyloid Angiopathy
David M. Stern - Great Neck NY Ann Marie Schmidt - Franklin Lakes NJ Shi Du Yan - New York NY Berislav Zlokovic - Rochester NY
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A01N 6100
US Classification:
514 1, 514 2, 514 44, 800 3, 5303871
Abstract:
The present invention provides a method for decreasing cerebral vasoconstriction in a subject suffering from chronic or acute cerebral amyloid angiopathy which comprises administering to the subject an inhibitor of receptor for advanced glycation endproduct (RAGE) in an effective amount to inhibit transcytosis of amyloid peptides across the blood-brain barrier in the subject, thereby decreasing cerebral vasoconstriction in the subject. The invention further provides for a method for ameliorating neurovascular stress in a subject which comprises administering to the subject an effective amount of an inhibitor of receptor for advanced glycation endproduct (RAGE), so as to increase cerebral blood flow in the subject, thereby ameliorating neurovascular stress in the subject.
Transgenic Mice Over-Expressing Amyloid-Beta Alcohol Dehydrogenase (Abad) In Brain As Model Of Alzheimer's Disease And Uses Thereof
The present invention provides for a transgenic non-human animal whose cells contain a recombinant DNA sequence comprising a nerve tissue specific promoter operatively linked to a DNA sequence which encodes amyloid-beta peptide alcohol dehydrogenase (ABAD), and exhibits at least one phenotype from the group consisting of: overexpression of ABAD, elevated levels of basal ATP; protection from metabolic or ischemic stress.
Dana C. DeMeo - Lake Grove NY, US David Stern - Centereach NY, US Thomas Wulff - North Patchogue NY, US
Assignee:
Symbol Technologies, Inc. - Holtsville NY
International Classification:
G06F011/00
US Classification:
714 6, 714727
Abstract:
An architecture for updating corrupted instructions in a computing device. The computing device includes a housing for enclosing a flash memory for storing a boot loader routine, and at least one boundary-scan device internal to the computing device for processing the boot loader routine, and operatively disposed on a boundary-scan bus. The housing includes a boundary-scan port through which updated instructions are communicated and power provided. The port is concealed under a label, cover, or in a location that limits access by the device owner, such as the battery well.
Name / Title
Company / Classification
Phones & Addresses
Mr David Stern Owner
David Stern Jewelers Jewelers - Retail. Jewelry Buyers
David F. Stern has concentrated his practice in the area of workers’ compensation litigation since graduation from The University of Pittsburgh School of Law. Mr. Stern has been representing injured w...
Tagline:
The Unmistakable Choice in Workers' Compensation and Social Security Disability Law
David Stern
Work:
Slate Magazine - Senior Product Manager
Education:
London School of Economics, Cornell University
David Stern
Work:
Self-Employed (1995) USC - Sr. Mgr. of Operations/Hospitality (2009-2011)
Education:
Culinary Institute of America - Hospitality Management
David Stern
Work:
Google - Software Engineer (2012)
Education:
Brown University
Tagline:
Brown University
David Stern
Work:
Clearstone Venture Partners
Education:
Cornell University
About:
I invest in PEOPLE.
David Stern
Lived:
Brooklyn, NY
Work:
Hess Corporation - Manager
David Stern
Work:
Self Employed - Writer/Producer
About:
Yes, it's me.
Flickr
Youtube
David Stern's last draft pick announcement of...
Check out NBA League Commissioner David Stern as he makes the final dr...
Duration:
2m 57s
David Stern, longtime NBA commissioner, dies ...
Jeremy Schaap remembers longtime NBA commissioner David Stern, who die...
Duration:
4m 23s
David Stern Jim Rome Radio Argument Have you...
Jim Rome asks David Stern what we all want to know- if the NBA Draft L...
Duration:
4m 31s
NBA Commish David Stern to Jim Rome "Do you s...
Jim Rome intereviewed NBA Commisioner David Stern on his radio show to...
Duration:
4m 37s
David Stern: Judge, Jury & Executioner | Gilb...
Kenyon Martin and Gilbert Arenas are no strangers to being suspended d...
Duration:
9m 26s
NBA on TNT Honors David Stern | All-Star 2020
The Inside guys share their thoughts about the late NBA commissioner D...